Sientra shares up after company releases 2021 revenue estimates
The Goleta-based breast implant manufacturer Sientra expects growth in the fourth quarter of 2021 and estimates its “highest-ever breast products yearly revenue” of up to $81 million for the full year, the company said Jan. 10. Sientra reported that its preliminary unaudited revenue from operations for the fourth quarter of 2021 is expected to be Read More →
Amgen inks drug development deal worth up to $1.9B
Thousand Oaks-based Amgen has reached an agreement with Generate Biomedicines, a Massachusetts-based therapeutics company, to research, discover and create protein therapeutics, the company announced Jan. 6. According to the agreement, Amgen, one of the largest biotech companies in the world, will pay $50 million up front to fund the initial five programs, with a potential Read More →
2022 Forecast: Stock analysts break out crystal balls for region’s biggest companies
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Sonos wins ruling that Google violated its patents
The U.S. International Trade Commission ruled in favor of Santa Barbara-based Sonos once again on Jan. 6, with a finding that Google infringed on five Sonos patents relating to smart speakers and audio. The ITC reaffirmed its decision from August, stating that Google violated section 337 of the Tariff Act of 1930 by infringing on Read More →
Region’s corporate boards meet state diversity standard
All of the tri-county region’s publicly held companies that trade on major stock exchanges meet California’s new requirement for more diversity on corporate boards. Assembly Bill 979 was passed in 2020 and went into effect on Jan. 1, 2022. It is similar to Senate Bill 826, a law that went into effect Jan. 1, 2019, Read More →
2021: The Year In Review
The Dec. 31 print edition of the Pacific Coast Business Times marks our annual Year In Review, featuring the biggest and best stories we published in 2021. Here is a look through our archives at the past year, a year marked by big deals, economic recovery and public health victories, but also by recurring waves Read More →
Amgen’s new asthma treatment gets FDA approval
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
